| Description |
1 online resource (465 p.) |
| Contents |
Cover -- Title Page -- Copyright Page -- Contents -- LIST OF CONTRIBUTORS -- FOREWORD -- PREFACE -- CHAPTER 1 INTRODUCTION: AN OVERVIEW OF NANOSIZED EMULSIONS -- 1.1. INTRODUCTION -- 1.2. CONCLUSION -- REFERENCES -- CHAPTER 2 FORMULATION DEVELOPMENT OF OIL-IN-WATER NANOSIZED EMULSIONS -- 2.1. INTRODUCTION -- 2.2. FDA-APPROVED OILS, EMULSIFIERS, AND AUXILIARY OR MISCELLANEOUS EXCIPIENTS -- 2.3. CURRENT AND NEAR FUTURE DIRECTION -- 2.4. LIPOPHILIC API INCORPORATION PATTERN INTO NANOSIZED EMULSIONS -- 2.5. QbD APPROACH TO OPTIMIZE EMULSION -- 2.6. CONCLUSION -- REFERENCES |
|
CHAPTER 3 CHARACTERIZATION AND SAFETY ASSESSMENT OF OIL-IN-WATER NANOSIZED EMULSIONS -- 3.1. INTRODUCTION -- 3.2. PHYSICAL AND VISUAL EVALUATIONS -- 3.3. CHEMICAL AND BIOLOGICAL EVALUATIONS -- 3.4. SAFETY AND EFFICACY ASSESSMENTS -- 3.5. CONCLUSION -- REFERENCES -- CHAPTER 4 MANUFACTURING AND POSITIONING (GENERATIONS) OF OIL-IN-WATER NANOSIZED EMULSIONS -- 4.1. INTRODUCTION -- 4.2. GENERATIONS OF O/W NANOSIZED EMULSIONS -- 4.3. PREPARATION METHODS FOR API-FREE/LOADED O/W NANOSIZED EMULSIONS -- 4.4. CONCLUSION -- REFERENCES -- CHAPTER 5 BIOFATE OF NANOSIZED EMULSIONS -- 5.1. INTRODUCTION |
|
5.2. BIOFATE OF O/W NANOSIZED EMULSIONS -- 5.3. CLINICAL ISSUES OF FIRST-GENERATION NANOSIZED EMULSIONS -- 5.4. CONCLUSION -- REFERENCES -- CHAPTER 6 MEDICAL OR THERAPEUTICAL APPLICATIONS OF OIL-IN-WATER NANOSIZED EMULSIONS -- 6.1. INTRODUCTION -- 6.2. MEDICAL OR THERAPEUTICAL APPLICATIONS OF O/W NANOSIZED EMULSIONS -- 6.3. CONCLUSION -- REFERENCES -- PART I OVERVIEW OF TOCOL-BASED EMULSIONS, OXYGEN-CARRYING EMULSIONS, EMULSIONS WITH DOUBLE OR TRIPLE CARGOS AND EMULSION-LIKE DISPERSIONS |
|
CHAPTER 7 OVERVIEW OF TOCOL-BASED EMULSIONS, OXYGEN-CARRYING EMULSIONS, EMULSIONS WITH DOUBLE OR TRIPLE CARGOS AND EMULSION-LIKE DISPERSIONS -- CHAPTER 7.1 TOCOL-BASED NANOSIZED EMULSIONS -- 7.1.1. INTRODUCTION -- 7.1.2. FORMULATION DEVELOPMENT USING TOCOL -- 7.1.3. NON- AND PRE-CLINICAL SAFETY STUDIES -- 7.1.4. THERAPEUTIC APPLICATIONS -- 7.1.5. CONCLUSION -- REFERENCES -- CHAPTER 7.2 OXYGEN-CARRYING EMULSIONS -- 7.2.1. INTRODUCTION -- 7.2.2. RATIONALE FOR SELECTING PERFLUOROCARBON FOR IN VIVO OXYGEN TRANSPORT -- 7.2.3. FORMULATION OF STABLE INJECTABLE PERFLUOROCARBON EMULSIONS |
|
7.2.4. MULTIFUNCTIONAL PERFLUOROCARBON-BASED EMULSIONS -- 7.2.5. GENERATIONS AND HURDLES OF PERFLUOROCARBON-BASED NANOSIZED EMULSIONS AS OXYGEN CARRIERS -- 7.2.6. PROPOSED SOLUTIONS TO OVERCOME THE HURDLES OF PERFLUOROCARBON-BASED NANOSIZED EMULSIONS USED AS OXYGEN CARRIERS -- 7.2.7. CONCLUSION -- REFERENCES -- CHAPTER 7.3 NANOSIZED EMULSIONS FOR MULTIPLE MEDICAMENT LOADINGS, IMAGING, AND THERANOSTIC PURPOSES -- 7.3.1. INTRODUCTION -- 7.3.2. BRIEF REVIEW OF RESEARCH REPORTS ON NANOSIZED EMULSIONS FOR IMAGING AND THERANOSTIC PURPOSE |
| Notes |
Description based upon print version of record |
| Subject |
Drug delivery systems.
|
|
Emulsions.
|
|
Oils and fats -- Solubility
|
|
Drug Delivery Systems
|
|
Emulsions
|
|
emulsion.
|
|
Drug delivery systems
|
|
Emulsions
|
| Form |
Electronic book
|
| ISBN |
9781119585329 |
|
1119585325 |
|
